Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD Pharmaceutical Investing
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program Pharmaceutical Investing
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial Pharmaceutical Investing
Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea Pharmaceutical Investing
Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial Pharmaceutical Investing
BioHarvest Sciences Inc. (formerly, Canna-V-Cell Sciences Inc.) Closes Agreement and Plan of Merger and announces the Results of its Annual General Meeting and Special Meeting Cannabis Investing News
Lions Bay Mining Announces Non-Binding LOI to Acquire BioVaxys LLC, a Clinical Stage Biopharma Company Developing Immunotherapeutic Vaccines for Life-threatening Viral Infections and Cancers Biotech Investing
Revive Therapeutics Announces Research Partnership Agreement with the University of Wisconsin-Madison Pharmaceutical Investing
